MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Mark Ballantyne
Mark BallantyneCooley

Mark Ballantyne

Associate at Cooley

Lawyer

Deal Bio

Total Deals3
Valued Deals3
Total Value£ 1.14 B
Avg. Deal Size£ 381 M

Market Context

Sort

30 Sep 2019|United States|Pharmaceuticals
Dova Pharmaceuticals
Swedish Orphan Biovitrum (sobi)

Target: DOVA PHARMACEUTICALS

Bidder: SWEDISH ORPHAN BIOVITRUM AB (SOBI)

9 Service Providers

5 Target | 4 Bidder

26 Dealmakers

7 Target | 19 Bidder

£ 744 M

Value

10 May 2021|United States|Digital Services
AGILETHOUGHT
Liv Capital Acquisition Corp

Target: AGILETHOUGHT

Bidder: LIV CAPITAL ACQUISITION CORP

6 Service Providers

3 Target | 3 Bidder

36 Dealmakers

25 Target | 11 Bidder

£ 344 M

Value

03 Jun 2025|United States|Pharmaceuticals
Chase Therapeutics (specific Clinical-stage Assets)
Alto Neuroscience

Target: CHASE THERAPEUTICS (SPECIFIC CLINICAL-STAGE ASSETS)

Bidder: ALTO NEUROSCIENCE

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

10 Bidder | 1 Vendor

£ 54 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite